4.2 Article

Immunosuppressive, Anti-Inflammatory, and Antioxidant Effects of Simvastatin on Pristane Induced Arthritis

Journal

PAKISTAN JOURNAL OF ZOOLOGY
Volume 55, Issue 5, Pages 2349-2358

Publisher

ZOOLOGICAL SOC PAKISTAN
DOI: 10.17582/journal.pjz/20220214010205

Keywords

Simvastatin; Pristane; Arthritis; Anti-inflammatory; Antioxidant

Categories

Ask authors/readers for more resources

This study aimed to investigate the mechanism of action of simvastatin as an anti-rheumatoid arthritis drug. The findings suggest that simvastatin can relieve pristane-induced arthritis through immunomodulation, anti-inflammatory, and antioxidant effects, and may have potential for prevention of rheumatoid arthritis.
The current therapeutic approaches to the autoimmune disease rheumatoid arthritis depend mainly on synthetic anti-arthritis compounds that usually cause many adverse effects. The anti-arthritic effect of the hypocholesterolemic drug simvastatin (Sim) has been confirmed, however, its actual mechanism of action has not been investigated yet. Therefore, this study aimed to unveil the biochemical and molecular changes that accompany the application of Sim as anti-arthritic in a mouse model of pristane-induced arthritis. Female Swiss albino mice (20-30g) were randomly divided into 5 groups (n= 10/group): control, Sim control, pristane-induced arthritis, Sim co-treated, and Sim post-treated group. Sim treatment significantly 1) downregulated the expression of immunomodulatory genes [interferon gamma (IFN gamma) and lactoferrin (LF)], 2) decreased the expression of inflammation-related genes [tumor necrosis factor alpha (TNF alpha) and interleukin 1 beta (IL1 beta)], 3) declined the expression of matrix metalloproteinase-3 (MMP3), transforming growth factor beta (TGF beta), and oxidized-LDL receptor (OLR1), 4) upregulated the expression of the anti-inflammatory gene IL10, 5) reduced the levels of the oxidative markers [lipid peroxide marker malondialdehyde (MDA) and nitric oxide (NO)], 6) increased the levels of antioxidant markers [reduced glutathione (GSH) and superoxide dismutase (SOD)]. These findings conclude that administration of Sim relieved pristane-induced arthritis, with best improvement in the Sim co-treated (prevention) group. Thus, Sim could be used as a protective drug against rheumatoid arthritis based on its immunomodulatory, anti-inflammatory, and antioxidant effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available